Table of Contents Author Guidelines Submit a Manuscript
Journal of Chemistry
Volume 2017, Article ID 5285671, 10 pages
https://doi.org/10.1155/2017/5285671
Research Article

A Stability-Indicating RP-HPLC-UV Method for Determination and Chemical Hydrolysis Study of a Novel Naproxen Prodrug

1Department of Pharmaceutical Chemistry, College of Pharmacy, Omdurman Islamic University, P.O. Box 2587, 11452 Khartoum, Sudan
2Department of Pharmaceutical Chemistry, College of Pharmacy, University of Medical Sciences and Technology, P.O. Box 12810, Khartoum, Sudan

Correspondence should be addressed to Mohamed H. M. Hamid; moc.liamg@2olohrd

Received 9 April 2017; Revised 7 August 2017; Accepted 17 August 2017; Published 25 October 2017

Academic Editor: Orazio Nicolotti

Copyright © 2017 Mohamed H. M. Hamid and Tilal Elsaman. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Lohar, S. Singhal, and V. Arora, “Prodrug: approach to better drug delivery,” International Journal of Pharmaceutical Research, vol. 4, no. 1, pp. 15–21, 2012. View at Google Scholar
  2. T. Elsaman, O. A. A. Aldeeb, T. Aboul-Fadl, and E. I. Hamedelneil, “Synthesis, characterization and pharmacological evaluation of certain enzymatically cleavable NSAIDs amide prodrugs,” Bioorganic Chemistry, vol. 70, pp. 144–152, 2017. View at Publisher · View at Google Scholar · View at Scopus
  3. A. M. Qandil, “Prodrugs of nonsteroidal anti-inflammatory drugs (NSAIDs), more than meets the eye: A critical review,” International Journal of Molecular Sciences, vol. 13, no. 12, pp. 17244–17274, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. P. K. Halen, P. R. Murumkar, R. Giridhar, and M. R. Yadav, “Prodrug designing of NSAIDs,” Mini-Reviews in Medicinal Chemistry, vol. 9, no. 1, pp. 124–139, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Kumar, D. K. Tyagi, and A. Gupta, “Synthesis, characterization and pharmcological activity of ester prodrugs of naproxen,” Asian Journal of Pharmaceutical and Clinical Research, vol. 3, no. 3, pp. 208–211, 2010. View at Google Scholar
  6. P. C. Sharma, S. Yadav, R. Pahwa, D. Kaushik, and S. Jain, “Synthesis and evaluation of novel prodrugs of naproxen,” Medicinal Chemistry Research, vol. 20, no. 5, pp. 648–655, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Elsaman and M. M. Ali, “Nonsteroidal anti-inflammatory drugs ( NSAIDs ) derivatives with anti-cancer activity,” American Journal of Research Communication, vol. 4, no. 4, 2016. View at Google Scholar
  8. L. F. Wang, H. N. Chiang, and W. B. Chen, “Synthesis and properties of a naproxen polymeric prodrug,” Journal of Pharmacy and Pharmacology, vol. 54, no. 8, pp. 1129–1135, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. V. R. Shanbhag, A. M. Crider, R. Gokhale, A. Harpalani, and R. M. Dick, “Ester and amide prodrugs of ibuprofen and naproxen: Synthesis, anti‐inflammatory activity, and gastrointestinal toxicity,” Journal of Pharmaceutical Sciences, vol. 81, no. 2, pp. 149–154, 1992. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Deb, J. Majumder, S. Bhattacharyya, and S. S. Jana, “A novel naproxen derivative capable of displaying anti-cancer and anti-migratory properties against human breast cancer cells,” BMC Cancer, vol. 14, no. 1, article no. 567, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Azizian, Z. Mousavi, H. Faraji et al., “Arylhydrazone derivatives of naproxen as new analgesic and anti-inflammatory agents: Design, synthesis and molecular docking studies,” Journal of Molecular Graphics and Modelling, vol. 67, pp. 127–136, 2016. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Thing, Y. Lu, L. Ågårdh et al., “Prolonged naproxen joint residence time after intra-articular injection of lipophilic solutions comprising a naproxen glycolamide ester prodrug in the rat,” International Journal of Pharmaceutics, vol. 451, no. 1-2, pp. 34–40, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Rautio, T. Nevalainen, H. Taipale et al., “Piperazinylalkyl prodrugs of naproxen improve in vitro skin permeation,” European Journal of Pharmaceutical Sciences, vol. 11, no. 2, pp. 157–163, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Larsen, “Quantitative determination of dextran-naproxen ester pro-drugs with varying molecular weights and degrees of substitution in biological media by means of high-performance size exclusion chromatography with fluorescence detection,” Journal of Pharmaceutical and Biomedical Analysis, vol. 7, no. 10, pp. 1173–1181, 1989. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Sheha, A. Khedr, and H. Elsherief, “Biological and metabolic study of naproxen-propyphenazone mutual prodrug,” European Journal of Pharmaceutical Sciences, vol. 17, no. 3, pp. 121–130, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. M. H. Helal, S. Y. Abbas, M. A. Salem, A. A. Farag, and Y. A. Ammar, “Synthesis and characterization of new types of 2-(6-methoxy-2-naphthyl) propionamide derivatives as potential antibacterial and antifungal agents,” Medicinal Chemistry Research, vol. 22, no. 11, pp. 5598–5609, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Spadaro, A. Bucolo, C. Ronsisvale, and G. Pappalardo, “Design, synthesis and antiinflammatory activity of novel alfa -tocopherol,” Journal of Pharmaceutical Sciences and Research, vol. 1, no. 4, pp. 88–95, 2009. View at Google Scholar
  18. G. Forte, I. Chiarotto, I. Giannicchi et al., “Characterization of naproxen-polymer conjugates for drug-delivery,” Journal of Biomaterials Science, Polymer Edition, vol. 27, no. 1, pp. 69–85, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Najlah, S. Freeman, D. Attwood, and A. D'Emanuele, “Synthesis, characterization and stability of dendrimer prodrugs,” International Journal of Pharmaceutics, vol. 308, no. 1-2, pp. 175–182, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Aboul-Fadl, T. Elsaman, O. A. Al-Deeb, H. A. Ghabbour, C. S. C. Kumar, and H.-K. Fun, “Some new NSAIDs prodrugs: an efficient synthesis, spectral characterization and X-ray crystal structure studies,” Asian Journal of Chemistry, vol. 26, no. 16, pp. 5249–5254, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. ICH, Stability Testing of New Drug Substances and Products Q1A(R2), Int. Conf. Harmon, no. February, 2003.
  22. S. Niazi, Handbook of Pharmaceutical Manufacturing Formulations, CRC Press, 2009. View at Publisher · View at Google Scholar
  23. ICH., ICH, Validation of Analytical Procedures: Text and Methodology, Int. Conf. Harmon, no. November, 1996.